Lucia Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.96M

  • Investors
  • 3

Lucia Bio General Information

Description

Developer of small molecule inhibitors intended for therapeutic application in immune-related diseases. The company offers compounds with tailored drug-like properties that target a clinically validated kinase, supported by preclinical data across neuroinflammatory, autoimmune, and hematologic indications, enabling pharmaceutical researchers and clinical developers to pursue precision treatment strategies with enhanced selectivity, reduced off-target effects, and potential for broad disease coverage.

Contact Information

Website
www.lucia.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 117 Camberwell Road
  • Suite 1.01, Hawthorn East Victoria
  • Camberwell, Victoria 3123
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 117 Camberwell Road
  • Suite 1.01, Hawthorn East Victoria
  • Camberwell, Victoria 3123
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lucia Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 28-Jul-2025 $1.96M Completed Generating Revenue
1. Joint Venture 01-Jan-2024 Completed Generating Revenue
To view Lucia Bio’s complete valuation and funding history, request access »

Lucia Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lucia Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
UniQuest Extension Fund Venture Capital Minority
Uniseed Venture Capital Minority
Molecule to Medicine Corporation Majority
To view Lucia Bio’s complete investors history, request access »

Lucia Bio FAQs

  • When was Lucia Bio founded?

    Lucia Bio was founded in 2024.

  • Where is Lucia Bio headquartered?

    Lucia Bio is headquartered in Camberwell, Australia.

  • What is the size of Lucia Bio?

    Lucia Bio has 4 total employees.

  • What industry is Lucia Bio in?

    Lucia Bio’s primary industry is Drug Discovery.

  • Is Lucia Bio a private or public company?

    Lucia Bio is a Private company.

  • What is Lucia Bio’s current revenue?

    The current revenue for Lucia Bio is .

  • How much funding has Lucia Bio raised over time?

    Lucia Bio has raised $1.96M.

  • Who are Lucia Bio’s investors?

    UniQuest Extension Fund, Uniseed, and Molecule to Medicine have invested in Lucia Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process